Miracle Mile Advisors, LLC Cyma Bay Therapeutics, Inc. Transaction History

Miracle Mile Advisors, LLC

  • $4.15 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 18, 2022
SELL
$3.23 - $4.6 $80,750 - $114,999
-25,000 Reduced 50.0%
25,000 $85,000
Q3 2021

Nov 01, 2021
BUY
$3.47 - $4.42 $86,750 - $110,500
25,000 Added 100.0%
50,000 $183,000
Q4 2019

Feb 10, 2020
BUY
$1.33 - $5.93 $33,250 - $148,250
25,000 New
25,000 $49,000

Others Institutions Holding CBAY

# of Institutions
6
Shares Held
1.82M
Call Options Held
0
Put Options Held
0
View Full List

About CymaBay Therapeutics, Inc.

CBAY Quotes by TradingView
  • Ticker CBAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,677,904
  • Description
  • CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...
More about CBAY
Track This Portfolio

Track Miracle Mile Advisors, LLC Portfolio

Follow Miracle Mile Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Miracle Mile Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miracle Mile Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email